- Integrated genomic and transcriptomic analysis suggests KRT18 mutation and MTAP are key genetic alterations related to the prognosis between astrocytoma and glioblastomaLi, Zhiyong; Jin, Yinghui; Zou, Qingping; Shi, Xiaofeng; Wu, Qianchao; Lin, Zhiying; He, Qun; Huang, Guanglong*; Qi, Songtao*Annals of Translational Medicine, 2021, 9(8): 713.被引 5
- Mutational profiling of newly diagnosed glioblastoma to identify predictive biomarkers of efficacy and safety of anlotinib combination therapy.Lai, Shuzhen; Li, Peijing; Liu, Xiaohui; Liu, Guihong; Xie, Tieming; Zhang, Xing; Wang, Xiaoxuan; Huang, Jing; Tang, Yiqiang; Liu, Zhigang; Shen, Guoping; Li, Chaoming; Lu, Fangxiao; Wang, Lei; Jiang, Fagui; Sun, Caixing; Chen, Yuan Yuan YuanAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- Progressively Metastasizing Ependymoma: Genomic AberrationsHendrik, Witt; Andrey, Korshunov; Marc, Remke; Stefan M., Pfister; Olaf, Witt; Till, MildeTumors of the Central Nervous System, Volume 8, Springer Netherlands, 297-306, 2012.
会议论文
Integrated genomic and transcriptomic analysis identified KRT18 mutation and MTAP loss as key genetic alterations related to the prognosis of astrocytoma and glioblastoma.
5阅读
